Medrx 9-Mos Loss Y320.00M Vs Loss Y671.00M

Dow JonesNov 8 14:32

Medrx Sees FY Loss Y846.00M

Dow JonesNov 8 14:32

Medrx: Summary of Financial Results for the 3rd Quarter Ending 2024/12 [Japanese GAAP] (Consolidated)

JPXNov 8 14:30 · Announcements

Morinaga Milk, mcdonald's, Toyo Suisan, Eisai (8th) (1429-5463)

※Please note that the above calendar is tentative and subject to change based on the company's convenience. --------------------------------------- November 8th (Fri) <1429> Japan Aqua <1435> RoboHome <143A> Ishin <1450> Tanaka Construction Industry <1451> KHC <1518> Mitsui Matsushima HD <151A> Dai <167A> Ryo

Fisco JapanNov 8 05:30

Emerging markets stocks digest: Fulta continues to rise significantly, sea U sea hits the daily limit.

<4598> DELTA-P 533 +47 surged significantly. After the trading on the 28th, the progress of the phase 1/2 clinical trial of DFP-10917 and VEN was announced, which is considered a positive development. DFP-10917, when given as a low-dose continuous infusion, is believed to be highly safe, stops cancer cells in the G2/M phase, and induces apoptosis (programmed cell death). Therefore, a strong synergistic effect can be expected when combined with VEN (a BCL-2 inhibitor). Currently, a phase 1 clinical trial is underway.

Fisco JapanOct 29 14:35

Hot stocks digest (morning session): Sakura, LITALICO, Flutta, etc.

Trading at the daily price limit. The company announced its first-half financial results the previous day, with an operating profit of 1.3 billion yen, which is 5.2 times higher than the same period last year, exceeding the upward revised figure of 1.1 billion yen on September 20th.

Fisco JapanOct 29 10:39